Interleukin-13 promotes expression of Alix to compromise renal tubular epithelial barrier function.

about

Platelet endothelial cell adhesion molecule-1 (PECAM1) plays a critical role in the maintenance of human vascular endothelial barrier function.

P2860

Q53406734-DB3C2C5B-9FFE-43E9-9DFB-49F19E0C1246

P2860

Interleukin-13 promotes expression of Alix to compromise renal tubular epithelial barrier function.

Item

http://www.wikidata.org/entity/Q38918934

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Interleukin-13 promotes expres ...... r epithelial barrier function.

@en

type

Item

label

Interleukin-13 promotes expres ...... r epithelial barrier function.

@en

prefLabel

Interleukin-13 promotes expres ...... r epithelial barrier function.

@en

P1476

Interleukin-13 promotes expres ...... r epithelial barrier function.

@en

P2093

Chen Xu

http://www.w3.org/2001/XMLSchema#string

Guangdong Sun

http://www.w3.org/2001/XMLSchema#string

Jie Yang

http://www.w3.org/2001/XMLSchema#string

Qianmei Sun

http://www.w3.org/2001/XMLSchema#string

Zhaohui Tong

http://www.w3.org/2001/XMLSchema#string

P2860

Review article: the role of anti-TNF in the management of ulcerative colitis -- past, present and future

A high-powered view of the filtration barrier.

Microbial products induce claudin-2 to compromise gut epithelial barrier function.

Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2R.

Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis.

Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model.

TNFAIP3 facilitates degradation of microbial antigen SEB in enterocytes

Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients?

Do Alix and ALG-2 really control endosomes for better or for worse?

Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors.

P304

548-553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CBIN.10433

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25597757

http://www.w3.org/2001/XMLSchema#string

Interleukin-13 promotes expression of Alix to compromise renal tubular epithelial barrier function.

about

P2860

P2860

Interleukin-13 promotes expression of Alix to compromise renal tubular epithelial barrier function.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698